<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00902109</url>
  </required_header>
  <id_info>
    <org_study_id>SCOPE-G-BETA</org_study_id>
    <nct_id>NCT00902109</nct_id>
  </id_info>
  <brief_title>Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients</brief_title>
  <acronym>TRASCO</acronym>
  <official_title>Pilot Study to Compare the Humphrey Field Analyzer (HFA) 30-2 Swedish Interactive Threshold Algorithm (SITA) Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE), Using a New Fast GATE (German Adaptive Threshold Estimation) in Glaucoma Patients Under Topic Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the two psychophysical perimetric techniques
      regarding progression of the visual field.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of rate of progression</measure>
    <time_frame>36 month</time_frame>
    <description>Perimetric measures every 3 month over 3 years</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Primary Open Angle Glaucoma (POAG)</condition>
  <arm_group>
    <arm_group_label>perimetry, HRT, OCT</arm_group_label>
    <description>perimetry, HRT, OCT</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Perimetry</intervention_name>
    <description>different perimetric devices, different perimetric grids: Octopus: New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) HFA: 30-2, Sita (Swedish Interactive Thresholding Algorithm) full threshold</description>
    <arm_group_label>perimetry, HRT, OCT</arm_group_label>
    <other_name>Humphrey Field Analyzer 745i (HFA), Interzeag Octopus 101</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Confocal Scanning Laser Tomography</intervention_name>
    <description>HRT examinations for the clinical evaluation of the optic disc.</description>
    <arm_group_label>perimetry, HRT, OCT</arm_group_label>
    <other_name>Heidelberg Retina Tomograph (HRT)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography (OCT)</intervention_name>
    <description>imaging of the retinal nerve fiber layer</description>
    <arm_group_label>perimetry, HRT, OCT</arm_group_label>
    <other_name>Spectralis-OCT (Heidelberg Engineering, Heidelberg, Germany)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        University Eye Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary open angle glaucoma (POAG)

          -  spherical ametropia max. ± 8 dpt

          -  cylindrical ametropia max. ± 3 dpt

          -  distant visual acuity &gt; 10/20

          -  pupil diameter &gt; 3 mm

        Exclusion Criteria:

          -  diabetic retinopathy

          -  asthma

          -  history of epilepsy or significant psychiatric disease

          -  medications known to effect visual field sensitivity

          -  infections (e.g., keratitis, conjunctivitis, uveitis)

          -  severe dry eyes

          -  miotic drug

          -  squint

          -  nystagmus

          -  albinism

          -  any ocular pathology, in either eye, that may interfere with the ability to obtain
             visual fields

          -  keratoconus

          -  intraocular surgery (except for uncomplicated cataract surgery) performed &lt; 3 month
             prior to screening

          -  history or signs of any visual pathway affection other than glaucoma

          -  history or presence of macular disease and/or macular edema, ocular trauma,
             medications known to affect visual field sensitivity
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Schiefer, Prof. Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Tuebingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute for Ophthalmic Research</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Schiefer U, Pascual JP, Edmunds B, Feudner E, Hoffmann EM, Johnson CA, Lagrèze WA, Pfeiffer N, Sample PA, Staubach F, Weleber RG, Vonthein R, Krapp E, Paetzold J. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Invest Ophthalmol Vis Sci. 2009 Jan;50(1):488-94. doi: 10.1167/iovs.08-2229. Epub 2008 Dec 5.</citation>
    <PMID>19060285</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2009</study_first_submitted>
  <study_first_submitted_qc>May 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2009</study_first_posted>
  <last_update_submitted>January 31, 2016</last_update_submitted>
  <last_update_submitted_qc>January 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Ulrich Schiefer</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>visual field</keyword>
  <keyword>perimetry</keyword>
  <keyword>progression</keyword>
  <keyword>POAG</keyword>
  <keyword>glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
    <mesh_term>Scotoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

